1.
|
Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: 21 and under Sponsor: NCI, Other Protocol IDs: AHEP0731, NCI-2011-01975, CDR0000654889, COG-AHEP0731, U10CA098543, NCT00980460
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 20 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: 100220, IND 59,056, NCT01222780
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 12 and over Sponsor: Other Protocol IDs: 11-211, NCT01642186
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: SorIrin1576, NCT01518413
|
|
5.
|
Phase: Phase I Type: Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: RADIANT, NCT01625351
|
|
6.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000554417, JHOC-J0685, NA_00003073, J0685, NCT00499733
|
|
7.
|
Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
|